Delivery Order SPE2DB24D1205-SPE2DB25FCYDX
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,339.30 firm-fixed-price contract is for the supply of testosterone 1% (50 mg/5 g) packs with a completion date of November 26, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,367.04, is for the delivery of Testosterone 1% (50 mg/5 g) pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, the prime contractor. The contract is for the supply of 50 mg/5 g Testosterone 1% pharmaceuticals, with a potential value of $1,481.52 and a completion date of February 8, 2024. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a for-profit organization that provides a wide range of pharmaceutical products and medical supplies...
- The Defense Logistics Agency awarded a $1,314.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with an ultimate completion date of July 1, 2025. This non-set-aside competitive award was issued on June 30, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal pharmaceutical supply...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of Testosterone 1% (50 mg/5 g) pharmaceutical products, with a potential value of $1,256.38 and a completion date of February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) it holds...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,055.46 firm-fixed-price delivery order is for the supply of testosterone 1% (25mg/2.5g) pharmaceutical products. The contract has a completion date of November 1, 2024 and is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite...
- The Defense Logistics Agency awarded a $1,431.29 delivery order to AmerisourceBergen Drug Corp for Testosterone 1% (50 mg/5 g) in unit dose 5-gram packets under a firm fixed-price contract type. The award was made on June 2, 2025, with an ultimate completion date of June 3, 2025, and represents a non-competitive, non-set-aside procurement. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,708.69 firm fixed-price delivery order is for the supply of Testosterone 1% (25mg/2.5g) medication, with an ultimate completion date of July 16, 2025. The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,642.58, is for the delivery of testosterone 1% (50 mg/5 g) in packages of 5 grams. This is a firm fixed-price delivery order contract with a completion date of February 20, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Testosterone 1% (50 mg/5 g) in unit dose packets of 5 grams. This competitively awarded, non-set-aside contract carries a ceiling value of $1,493.80 and represents a firm fixed-price delivery order with an ultimate completion date of August 5, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCYDXDelivery Order
This is a $1,567.48 Firm Fixed Price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of Testosterone 1% (50 mg/5 g) in 5 g packs. The award has an ultimate completion date of July 2, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order falls under that larger IDC, enabling Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The contract does not have a set-aside designation, indicating open competition. As a major supplier of medical and pharmaceutical products to federal agencies, Amerisourcebergen leverages its expertise to fulfill diverse requirements for medications across multiple therapeutic areas, both brand-name and generic, in support of military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 7/1/25 |